WallStSmart
TELA

Tela Bio Inc

NASDAQ: TELA · HEALTHCARE · MEDICAL DEVICES

$0.87
+1.72% today

Updated 2026-04-30

Market cap
$34.90M
P/E ratio
P/S ratio
0.44x
EPS (TTM)
$-0.83
Dividend yield
52W range
$1 – $2
Volume
0.2M

WallStSmart proprietary scores

33
out of 100
Grade: F
Strong Sell
Investment rating
7.3
Growth
B+
5.8
Quality
C+
2.0
Profitability
F
6.7
Valuation
B
5/9
Piotroski F-Score
Moderate
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
$2.25
+157.20%
12-Month target
Intrinsic (DCF)
$7.70
Margin of safety
+89.79%

Price chart

X-Ray snapshot

Strengths
+ Revenue growth 18.20% QoQ
+ 89.79% below intrinsic value
Risks
- Thin margins at -48.40%
- Negative free cash flow $-4.96M
- Debt/equity 26.98x — high leverage

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$41.42M$58.45M$69.30M$80.28M$80.28M
Net income$-44.30M$-46.66M$-37.84M$-38.83M$-9.04M
EPS$-0.83
Free cash flow$-42.62M$-41.47M$-42.58M$-28.67M$-4.96M
Profit margin-106.95%-79.83%-54.60%-48.37%-48.40%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
TELA$34.90M337.32.06.75.8+89.79%Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$336.47B545.35.57.34.8+42.09%Buy
AZN$287.11B646.78.05.35.0+4.07%Buy

Smart narrative

Tela Bio Inc trades at $0.87. Our Smart Value Score of 33/100 indicates the stock is weak. The company scores 5/9 on the Piotroski F-Score. TTM revenue stands at $80.28M. with profit margins at -48.40%. Our DCF model estimates intrinsic value at $7.70.

Frequently asked questions

What is Tela Bio Inc's stock price?
Tela Bio Inc (TELA) trades at $0.87.
Is Tela Bio Inc overvalued?
Smart Value Score 33/100 (Grade F, Strong Sell). DCF value $7.70.
What is the price target of Tela Bio Inc (TELA)?
The analyst target price is $2.25, representing +157.2% upside from the current price of $0.87.
What is the intrinsic value of Tela Bio Inc (TELA)?
Based on our DCF model, intrinsic value is $7.70, a +89.8% margin of safety versus $0.87.
What is Tela Bio Inc's revenue?
TTM revenue is $80.28M.
Piotroski F-Score?
5/9 — moderate financial health.

Company info

SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio0.44x
ROE-223.30%
Beta0.99
50D MA$0.73
200D MA$1.22
Shares out0.04B
Float0.02B
Short ratio
Avg volume0.2M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years